Prostatis Group’s F/m US Treasury 3 Month Bill Fund TBIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
22,151
-1,946
-8% -$97.1K 0.26% 73
2026
Q1
$1.2M Buy
24,097
+40
+0.2% +$2K 0.31% 71
2025
Q4
$1.2M Buy
24,057
+3,049
+15% +$152K 0.29% 68
2025
Q3
$1.05M Sell
21,008
-2,736
-12% -$137K 0.26% 74
2025
Q2
$1.19M Buy
23,744
+3,810
+19% +$190K 0.34% 66
2025
Q1
$997K Sell
19,934
-1,157
-5% -$57.8K 0.31% 68
2024
Q4
$1.05M Buy
+21,091
New +$1.05M 0.31% 69
2024
Q3
Sell
-10,886
Closed -$545K 150
2024
Q2
$545K Buy
+10,886
New +$544K 0.19% 92

Other funds holding TBIL

Prostatis Group's TBIL Position: Q2 2026 in Review

Prostatis Group reduced its F/m US Treasury 3 Month Bill Fund (TBIL) stake by 8.1% in Q2 2026, selling an estimated $97.1K and leaving 22,151 shares worth $1.1M. The position accounts for 0.26% of the portfolio, ranked #73.

Prostatis Group first reported a position in TBIL in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.2M in Q1 2026. 317 funds tracked by Wall St. Rank hold TBIL as of Q2 2026.

  • Prostatis Group held 22,151 shares of F/m US Treasury 3 Month Bill Fund worth $1.1M as of Q2 2026.
  • Prostatis Group sold 1,946 F/m US Treasury 3 Month Bill Fund shares in Q2 2026, an estimated $97.1K.
  • F/m US Treasury 3 Month Bill Fund made up 0.26% of Prostatis Group's portfolio in Q2 2026, its #73 holding.
  • Prostatis Group first reported a position in F/m US Treasury 3 Month Bill Fund in Q2 2024 and has held it in 8 quarters since.
  • Prostatis Group's F/m US Treasury 3 Month Bill Fund position peaked at $1.2M in Q1 2026.
  • 317 funds tracked by Wall St. Rank held F/m US Treasury 3 Month Bill Fund as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.